Skip to content

Gestational Diabetes: Induction Versus Expectant Management of Labour

GINEXMAL RCT: Induction of Labour Versus Expectant Management in Gestational Diabetes Pregnancies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01058772
Acronym
GINEXMAL
Enrollment
425
Registered
2010-01-29
Start date
2010-03-31
Completion date
2014-03-31
Last updated
2015-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Gestational, Diabetes, Pregnancy Induced, Gestational Diabetes, Gestational Diabetes Mellitus, Pregnancy-Induced Diabetes

Keywords

Induced Labour, Expectant Management, C-section rate, Maternal Outcomes, Neonatal Outcomes

Brief summary

The purpose of this study is to determine whether, in Gestational Diabetes Mellitus (GDM) pregnancies, induction of labour at 38-39 weeks of pregnancy is superior to expectant management in terms of maternal and neonatal outcomes.

Detailed description

Gestational Diabetes Mellitus (GDM) is one of the most common complications of pregnancy and its incidence is estimated as around 7%. Babies born from women with GDM are significantly more exposed to perinatal risk. Furthermore in GDM pregnancies an increased C-section rate has been observed, mostly unjustified. Strong evidence, based on prospective studies and randomized controlled trials, in favour or against the effectiveness and safeness of induction in women with GDM, are missing. The aim of the present study is to identify the best management for these women at term and provide evidence that could change the current clinical practice. To reach this objective, 1760 eligible women will be recruited at 9 Teaching Hospitals (5 in Italy, 4 all over the world). Sample size has been estimated to demonstrate a difference between the two arms ≥ 6% (31% of C-section in the expectant group and 25% in the induction group; relative difference between the 2 groups equal to 20% in favor of induction; Kjos et al, 1993), considering an α error equal to 5% and 80% power. Patients will be randomized to induction of labour (N=880) or expectant management (N=880). Data on maternal and neonatal outcomes will be collected at delivery and until maternal and neonatal discharge.

Interventions

OTHERINDUCTION of LABOUR

Induction of labour will be performed by using dinoprostone 2 mg vaginally or dinoprostone 0.5 mg intracervically at 6-8h interval (up to 5 doses) or dinoprostone 10 mg vaginal device. Patients, in which cervical ripening does not occur (Bishop score \< 7) after 5 attempts with PGE2, will be offered either oxytocin or Foley catheter induction or C-section, according to local protocols.

Sponsors

IRCCS Burlo Garofolo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Maternal age \> 18; * Singleton pregnancy in vertex presentation; * Gestational age between 38-39 weeks verified by LMP and first trimester ultrasound when available; * Women diagnosed with GDM in the current pregnancy \[Diagnosis will be based upon abnormal 50 Gr. GCT (\>140) followed by \>2 abnormal indices in the OGTT (according to C&C criteria). Women with GCT\>200 mg/dl will undergo 100 gr OGTT as well\]; * No other contraindications for vaginal delivery.

Exclusion criteria

* Pre-gestational diabetes; * Prior C-section; * Suspected estimated fetal weight\> 4000 gr. at enrollment; * Any known contraindications for vaginal delivery; * Uncertain gestational age; * Non-reassuring fetal status necessitating immediate obstetrical intervention (prompt delivery/prompt C-section); * Maternal disease complicating pregnancy and necessitating delivery (e.g Severe PET); * Bishop score \>7 at enrollment; * Major fetal malformation.

Design outcomes

Primary

MeasureTime frame
C-section rate1 minute after delivery

Secondary

MeasureTime frame
Maternal Blood Transfusionuntil maternal discharge
Maternal Intensive Care Unit Admissionuntil maternal discharge
Neonatal Weight10 minutes after delivery
Neonatal Apgar score at 1', 5', 10' minutes1, 5, 10 minutes after delivery
Shoulder Dystociaduring delivery
Manoeuvres for Shoulder Dystociaduring delivery
Neonatal Intensive Care Unit Admissionuntil neonatal discharge
Operative Vaginal Delivery1 minute after delivery
Perineal Tears or Episiotomy1 minute after delivery
Arterial cord Ph inferior to 7.2within 5 minutes from delivery
Postpartum haemorrhagewithin 24 hours from delivery
Clinical and Biochemical Neonatal Hypoglycemiauntil neonatal discharge
Neonatal Polycythemiauntil neonatal discharge
Neonatal Birth Trauma10 minute from delivery or until neonatal discharge
Neonatal Respiratory Distress/Transient Tachypneauntil neonatal discharge
Neonatal Need for Respiratory Supportuntil neonatal discharge
Maternal deathuntil neonatal discharge
Perinatal Deathuntil neonatal discharge
Spontaneous/Instrumental third stage of labourwithin 1 hours from delivery
Indication for Cesarean Section1 minutes after delivery
Neonatal Hyperbilirubinemiauntil neonatal discharge

Countries

Israel, Italy, Netherlands, Slovenia, Sri Lanka

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026